Review article · 2026 · Open access

Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition

Tapash Chakraborty, Shashanka Jyoti Kashyap, Pragyan Deep Chetia, Sumona Purkayastha

Frontiers in Systems Biology, 6, 1898890 · Published 7 August 2026 · DOI 10.3389/fsysb.2026.1898890

Open PDFView at the publisherCite this paper

In brief

“Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition” is a 2026 review article by Tapash Chakraborty and 3 co-authors, published in Frontiers in Systems Biology. OpenAlex counts 4 citations as of 18 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Systems Biology.

Citations
4
Most cited in
2026 (4)
Field-weighted impact
1.48
References
73
Authors
4

Abstract

Dietary bioactive compounds, particularly polyphenols and glucosinolates, are widely associated with reduced risk of chronic disease, yet fewer than 10% of most ingested polyphenols reach systemic circulation in their active form, a figure that varies markedly by compound class; resveratrol bioavailability is below 1%, whereas some simple phenolic acids may reach 30%-50%. The gut microbiota is the primary site where these compounds are chemically transformed into absorbable metabolites, but individuals vary enormously in their capacity to carry out this transformation. This review examines how gut microbiota-mediated biotransformation of dietary bioactive compounds is determined by three interacting factors: baseline microbiota composition, fermented food consumption, and probiotic or prebiotic supplementation. The review covers polyphenols, isoflavones, ellagitannins, glucosinolates, and alkaloids. Synthetic drugs and non-dietary administration routes are excluded. The three-factor framework collectively determines an individual's biotransformation phenotype, which governs how much of a given dietary bioactive reaches the bloodstream as an active metabolite. Documented examples include equol production from daidzein (present in only around 30% of Western adults), urolithin generation from ellagitannins (three distinct metabotypes in the population), and dihydroberberine production from berberine. Each of these variations produces measurable differences in health outcomes, including cardiovascular markers, glycaemic control, and muscle function. Biotransformation phenotyping is technically feasible through urine metabolomics and faecal enzyme assays. Personalised dietary guidance that accounts for an individual's biotransformation capacity has the potential to resolve the inconsistency that has characterised polyphenol intervention trials. Standardised phenotyping protocols, re-analysis of existing trial datasets, and updated regulatory frameworks represent the most urgent research priorities.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chakraborty, T., Kashyap, S. J., Chetia, P. D., & Purkayastha, S. (2026). Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition. Frontiers in Systems Biology, 6, 1898890. https://doi.org/10.3389/fsysb.2026.1898890

MLA 9

Chakraborty, Tapash, et al. “Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition.” Frontiers in Systems Biology, vol. 6, 2026, p. 1898890. https://doi.org/10.3389/fsysb.2026.1898890.

Chicago

Chakraborty, Tapash, Shashanka Jyoti Kashyap, Pragyan Deep Chetia, and Sumona Purkayastha. 2026. “Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition.” Frontiers in Systems Biology 6: 1898890. https://doi.org/10.3389/fsysb.2026.1898890.

Harvard

Chakraborty, T. et al. (2026) ‘Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition’, Frontiers in Systems Biology, 6, p. 1898890. doi:10.3389/fsysb.2026.1898890.

IEEE

T. Chakraborty, S. J. Kashyap, P. D. Chetia, and S. Purkayastha, “Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition,” Frontiers in Systems Biology, vol. 6, p. 1898890, 2026, doi: 10.3389/fsysb.2026.1898890.

BibTeX

@article{chakraborty2026microbiota,
  title     = {{Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition}},
  author    = {Chakraborty, Tapash and Kashyap, Shashanka Jyoti and Chetia, Pragyan Deep and Purkayastha, Sumona},
  journal   = {Frontiers in Systems Biology},
  year      = {2026},
  volume    = {6},
  pages     = {1898890},
  doi       = {10.3389/fsysb.2026.1898890},
  url       = {https://doi.org/10.3389/fsysb.2026.1898890}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • gut microbiota
  • biotransformation
  • dietary bioactive compounds
  • polyphenols
  • glucosinolates
  • isoflavones
  • ellagitannins
  • alkaloids

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Chakraborty, T., Kashyap, S. J., Chetia, P. D., & Purkayastha, S. (2026). Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition. Frontiers in Systems Biology, 6, 1898890. https://doi.org/10.3389/fsysb.2026.1898890

How many times has this paper been cited?

4 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Systems Biology: sign in and open the PDF from this page.

Who wrote this paper?

Tapash Chakraborty, Shashanka Jyoti Kashyap, Pragyan Deep Chetia, Sumona Purkayastha.

What is the DOI of this paper?

10.3389/fsysb.2026.1898890, permanently at https://doi.org/10.3389/fsysb.2026.1898890. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.